Circulating IL-1β levels, polymorphisms of IL-1B, and risk of cervical cancer in Chinese women

Journal of Cancer Research and Clinical Oncology

Volumn 136, Issue 5, 2010, Pages 709-716

  Qian, Nianfeng ^a   Chen, Xiaojun ^a,c   Han, Suping ^a,b   Qiang, Fulin ^c   Jin, Guangfu ^a   Zhou, Xiaoyi ^a   Dong, Jing ^a   Wang, Xinru ^a   Shen, Hongbing ^a   Hu, Zhibin ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c Tumor Hospital of Nantong City   (China)

Author keywords

Cervical cancer; IL 1 ; IL 1B; Molecular epidemiology; Polymorphism

Indexed keywords

BIOLOGICAL MARKER; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ADULT; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; DNA POLYMORPHISM; FEMALE; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; UTERINE CERVIX CANCER; VARIABLE NUMBER OF TANDEM REPEAT; BLOOD; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; RISK FACTOR; UTERINE CERVIX TUMOR;

CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1BETA; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 77950509934     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-009-0710-5     Document Type: Article

References (29)

1. Arend WP (2002) The balance between IL-1 and IL-1Ra in disease. Cytokine Growth Factor Rev 13:323-340
2. Arend WP, Malyak M, Guthridge CJ, Gabay C (1998) Interleukin-1 receptor antagonist: role in biology. Annu Rev Immuno l16:27-55
3. Behbakht K, Friedman J, Heimler I, Aroutcheva A, Simoes J, Faro S (2002) Role of the vaginal microbiological ecosystem and cytokine profile in the promotion of cervical dysplasia: a case-control study. Infect Dis Obstet Gynecol 10:181-186
4. Belokrinitskaia TE, Vitkovskii IuA, Ponomareva IuN (2003) Role of cytokines in the development of immunologic and homeostatic disorders in advanced dysplasia and carcinoma of the uterine cervix. Vopr Onkol 49:51-54
5. Bidwell J, Keen L, Gallagher G, Kimberly R, Huizinga T, McDermott MF et al (1999) Cytokine gene polymorphism in human disease: on-balance line databases. Genes Immun 1:3-19
6. Chang YW, Jang JY, Kim NH, Lee JW, Lee HJ, Jung WW et al (2005) Interleukin-1B (IL-1B) polymorphisms and gastric mucosal levels of IL-1βeta cytokine in Korean patients with gastric cancer. Int J Cancer 114:465-471
7. Chen H, Wilkins LM, Aziz N, Cannings C, Wyllie DH, Bingle C et al (2006) Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. Hum Mol Genet 15:519-529
8. Dinarello CA (1991) Interleukin-1 and interleukin-1 antagonism. Blood 77:1627-1652
9. Dinarello CA, Wolff SM (1993) The role of interleukin-1 in disease. N Engl J Med 328:106-113
10. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA et al (2000) Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404:398-402
11. El-Omar EM, Rabkin CS, Gammon MD, Vaughan TL, Risch HA, Schoenberg JB et al (2003) Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 124:1193-1201
12. Francis SE, Camp NJ, Dewberry RM, Gunn J, Syrris P, Carter ND et al (1999) Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease. Circulation 99:861-866
13. Fujiwaki R, Iida K, Nakayama K, Kanasaki H, Hata K, Katabuchi H et al (2003) Clinical significance of interleukin-1 receptor antagonist in patients with cervical carcinoma. Gynecol Oncol 89:77-83
14. Grimm C, Berger I, Tomovski C, Zeillinger R, Concin N, Leodolter S et al (2004) A polymorphism of the interleukin-1 receptor antagonist plays a prominent role within the interleukin-1 gene cluster in vulvar carcinogenesis. Gynecol Oncol 92:936-940
15. Hirankarn N, Kimkong I, Kummee P, Tangkijvanich P, Poovorawan Y (2006) Interleukin-1beta gene polymorphism associated with hepatocellular carcinoma in hepatitis B virus infection. World J Gastroenterol 12:776-779
16. Hu Z, Shao M, Chen Y, Zhou J, Qian J, Xu L et al (2006) Allele 2 of the interleukin-1 receptor antagonist gene (IL1RN*2) is associated with a decreased risk of primary lung cancer. Cancer Lett 236:269-275
17. Kang S, Kim JW, Park NH, Song YS, Park SY, Kang SB et al (2007) Interleukin-1 beta-511 polymorphism and risk of cervical cancer. J Korean Med Sci 22:110-113
18. Lind H, Haugen A, Zienolddiny S (2007) Differential binding of proteins to the IL1B-31 T/C polymorphism in lung epithelial cells. Cytokine 38:43-48
19. Liu J, Zhai X, Jin G, Hu Z, Wang S, Wang X et al (2006) Functional variants in the promoter of interleukin-1beta are associated with an increased risk of breast cancer: a case-control analysis in a Chinese population. Int J Cancer 118:2554-2558
20. Machado JC, Figueiredo C, Canedo P, Pharoah P, Carvalho R, Nabais S et al (2003) A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology 125:364-371
21. Mustea A, Sehouli J, Konsgen D, Stengel D, Sofroni D, Lichtenegger W (2003) Interleukin 1 receptor antagonist (IL-1 RA) polymorphism in women with cervical cancer. Anticancer Res 23:1099-1102 (Pubitemid 36752683)
22. Noqueira de Souza NC, Brenna SM, Campos F, Syrjänen KJ, Baracat EC, Silva ID (2006) Interleukin-6 polymorphisms and the risk of cervical cancer. Int J Gynecol Cancer 16:1278-1282
23. Parkin DM, Bray F (2006) Chapter 2: the burden of HPV related cancers. Vaccine 24:S11-S25
24. Santtila S, Savinainen K, Hurme M (1998) Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1βeta production in vitro. Scand J Immunol 47:195-198
25. Tarlow JK, Blakemore AI, Lennard A, Solari R, Hughes HN, Steinkasserer A et al (1993) Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 91:403-404
26. Tjiong MY, van der Vange N, ter Schegget JS, Burger MP, ten Kate FW, Out TA (2001) Cytokines in cervicovaginal washing fluid from patients with cervical neoplasia. Cytokine 14:357-360
27. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV et al (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12-19
28. Zeng ZR, Hu PJ, Hu S, Pang RP, Chen MH, Ng M et al (2003) Association of interleukin 1B gene polymorphism and gastric cancers in high and low prevalence regions in China. Gut 52:1684-1689
29. Zienolddiny S, Ryberg D, Maggini V, Skaug V, Canzian F, Haugen A (2004) Polymorphisms of the interleukin-1b gene are associated with increased risk of non-small cell lung cancer. Int J Cancer 109:353-356 (Pubitemid 38252762)